Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening

被引：23

作者：

Boers, Aniek ^{[1
]}

Wang, Rong ^{[1
]}

Slagter-Menkema, Lorian ^{[2
]}

van Hemel, Bettien M. ^{[2
]}

Ghyssaert, Hilde ^{[3
]}

van der Zee, Ate G. J. ^{[1
]}

Wisman, G. Bea A. ^{[1
]}

Schuuring, Ed ^{[2
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Div Gynecol Oncol, Dept Obstet & Gynecol, Groningen, Netherlands

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands

[3] AZ St Jan Brugge Oostende, Dept Pathol, Brugge, Belgium

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2014年 / 52卷 / 12期

关键词：

HIGH-RISK HPV; HYBRID CAPTURE 2; WOMEN; PERFORMANCE; CYTOLOGY; ASSAY; EXPERIENCE;

D O I：

10.1128/JCM.02716-14

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This study demonstrates that both the clinical sensitivity and specificity of the Cervista HPV HR test for high-risk human papillomavirus (HPV) detection are not inferior to those of the Hybrid Capture 2 (HC2) test. The intra- and interlaboratory reproducibilities of Cervista were 92.0% (kappa, 0.83) and 90.4% (kappa, 0.80), respectively. The Cervista HPV HR test fulfills all the international HPV test requirements for cervical primary screening purposes.

引用

页码：4391 / 4393

页数：3

共 17 条

[11] Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI [10.1097/LGT.0b013e318287d329, 10.1097/AOG.0b013e3182883a34]
[12] Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Meijer, Chris J. L. M.
Berkhof, Johannes
Castle, Philip E.
Hesselink, Albertus T.
Franco, Eduardo L.
Ronco, Guglielmo
Arbyn, Marc
Bosch, F. Xavier
Cuzick, Jack
Dillner, Joakim
Heideman, Danielle A. M.
Snijders, Peter J. F.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 516 - 520
[13] Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age
Quigley, Neil B.
Potter, Nicholas T.
Chivukula, Mamatha
Knight, Mirna Z.
Welche, James R.
Olson, Marilyn C.
[J]. JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (01) : 23 - 27
[14] Rossi PG, 2013, CURR PHARM DESIGN, V19, P1490
[15] Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the US Preventive Services Task Force
Whitlock, Evelyn P.
Vesco, Kimberly K.
Eder, Michelle
Lin, Jennifer S.
Senger, Caitlyn A.
Burda, Brittany U.
[J]. ANNALS OF INTERNAL MEDICINE, 2011, 155 (10) : 687 - +
[16] Clinical Experience with the Cervista HPV HR Assay Correlation of Cytology and HPV Status from 56,501 Specimens
Youens, Kenneth E.
Hosler, Gregory A.
Washington, Paula J.
Jenevein, E. Patrick
Murphy, Kathleen M.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (02) : 160 - 166
[17] Clinical Performance Characteristics of the Cervista HPV HR Test Kit in Cervical Cancer Screening in China
Zhao, Jian
Zhang, Xiaoguang
Ma, Jing
Liu, Guiwen
Yao, Dianxin
Zhang, Weiyuan
Wang, Jiandong
Wei, Lihui
Zhao, Yun
Zeng, Yi
Liao, Qinping
[J]. JOURNAL OF LOWER GENITAL TRACT DISEASE, 2012, 16 (04) : 358 - 363

← 1 2 →